"Graft vs Host Disease" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The clinical entity characterized by anorexia, diarrhea, loss of hair, leukopenia, thrombocytopenia, growth retardation, and eventual death brought about by the GRAFT VS HOST REACTION.
| Descriptor ID |
D006086
|
| MeSH Number(s) |
C20.452
|
| Concept/Terms |
Graft vs Host Disease- Graft vs Host Disease
- Graft-Versus-Host Disease
- Disease, Graft-Versus-Host
- Diseases, Graft-Versus-Host
- Graft Versus Host Disease
- Graft-Versus-Host Diseases
- Runt Disease
- Disease, Runt
- Graft-vs-Host Disease
- Disease, Graft-vs-Host
- Diseases, Graft-vs-Host
- Graft-vs-Host Diseases
- Homologous Wasting Disease
- Disease, Homologous Wasting
|
Below are MeSH descriptors whose meaning is more general than "Graft vs Host Disease".
Below are MeSH descriptors whose meaning is more specific than "Graft vs Host Disease".
This graph shows the total number of publications written about "Graft vs Host Disease" by people in this website by year, and whether "Graft vs Host Disease" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 2 | 7 | 9 |
| 1997 | 3 | 6 | 9 |
| 1998 | 0 | 1 | 1 |
| 1999 | 3 | 3 | 6 |
| 2000 | 4 | 6 | 10 |
| 2001 | 2 | 2 | 4 |
| 2002 | 2 | 3 | 5 |
| 2003 | 3 | 7 | 10 |
| 2004 | 3 | 5 | 8 |
| 2005 | 3 | 4 | 7 |
| 2006 | 4 | 3 | 7 |
| 2007 | 7 | 2 | 9 |
| 2008 | 4 | 2 | 6 |
| 2009 | 4 | 7 | 11 |
| 2010 | 6 | 4 | 10 |
| 2011 | 6 | 2 | 8 |
| 2012 | 5 | 1 | 6 |
| 2013 | 4 | 7 | 11 |
| 2014 | 2 | 2 | 4 |
| 2015 | 7 | 5 | 12 |
| 2016 | 1 | 10 | 11 |
| 2017 | 4 | 7 | 11 |
| 2018 | 0 | 4 | 4 |
| 2019 | 5 | 1 | 6 |
| 2020 | 10 | 1 | 11 |
| 2021 | 9 | 0 | 9 |
| 2022 | 9 | 0 | 9 |
| 2023 | 9 | 0 | 9 |
| 2024 | 4 | 1 | 5 |
| 2025 | 3 | 2 | 5 |
| 2026 | 2 | 1 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Graft vs Host Disease" by people in Profiles.
-
A Comparative Study of Mesenchymal Stem Cell Derived From Human Embryonic Stem Cell-derived Mesenchymal Stem Cells Through a Trophoblast-like Stage and Bone Marrow-derived Mesenchymal Stem Cells in Treating Acute Xenogeneic Graft-versus-host Disease in Humanized Mice. Transplantation. 2026 Aug 01; 110(8):e1649-e1656.
-
Haploidentical versus matched unrelated donor transplantation with post-transplant cyclophosphamide: a platform-dependent machine learning analysis of donor age. Leukemia. 2026 May; 40(5):1009-1017.
-
Orca-T vs allogeneic hematopoietic stem cell transplantation (Precision-T): a multicenter, randomized phase 3 trial. Blood. 2026 Mar 12; 147(11):1168-1177.
-
Abatacept improves posttransplant survival and reduces endothelial injury syndromes in ß-thalassemia major. Blood Adv. 2025 Dec 23; 9(24):6370-6379.
-
Hematopoietic Cell Transplantation, Version 3.2025, NCCN Clinical Practice Guidelines In Oncology. J Natl Compr Canc Netw. 2025 10; 23(10).
-
Acetyl-CoA carboxylase 1 inhibition increases Treg metabolism and graft-versus-host disease treatment efficacy via mitochondrial fusion. J Clin Invest. 2025 12 01; 135(23).
-
Intensified conditioning with high-dose total marrow irradiation and myeloablative chemotherapy reduces risk of relapse without increasing toxicity in allogeneic hematopoietic stem cell transplant for high-risk myeloid malignancies: a phase II study. Haematologica. 2026 01 01; 111(1):177-183.
-
Abatacept for acute graft versus host disease prophylaxis in children with sickle cell disease patients undergoing HLA identical sibling hematopoietic stem cell transplantation. Bone Marrow Transplant. 2025 08; 60(8):1102-1107.
-
Durable mixed chimerism may permit subsequent immunosuppression-free intestinal transplantation-A proof-of-principle study. Am J Transplant. 2025 Apr; 25(4):825-835.
-
Transplant Outcomes in Myelofibrosis: Impact of Donor Type (Cord Blood Grafts Supported by CD34+ selected Cells [Haplo-Cord] Versus Matched Donors). Transplant Cell Ther. 2024 11; 30(11):1100.e1-1100.e11.